Search Header Logo
What We Know About Long Covid

What We Know About Long Covid

Assessment

Interactive Video

Business, Health Sciences, Biology

University

Practice Problem

Hard

Created by

Wayground Content

FREE Resource

The transcript discusses the speaker's personal experience with Lyme disease and its long-term effects, drawing parallels to the emerging chronic condition of long COVID. It highlights the symptoms and challenges faced by long COVID patients, known as long haulers, and the efforts of Bio Incept, a biotech company focused on treating autoimmune diseases and promoting tissue regeneration. The speaker, who transitioned from a banking career to biotech, outlines Bio Incept's plans for a public listing and a study on long COVID, emphasizing the potential impact on patients and the healthcare system.

Read more

3 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

What is the focus of Bio Incept as mentioned in the text?

Evaluate responses using AI:

OFF

2.

OPEN ENDED QUESTION

3 mins • 1 pt

What unique opportunity did the speaker see in transitioning to Bio Incept?

Evaluate responses using AI:

OFF

3.

OPEN ENDED QUESTION

3 mins • 1 pt

What potential does the speaker see for Bio Incept in the near future?

Evaluate responses using AI:

OFF

Access all questions and much more by creating a free account

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

Already have an account?